Cellular signaling in the aging immune system - PubMed (original) (raw)
Review
Cellular signaling in the aging immune system
Tamas Fulop et al. Curr Opin Immunol. 2014 Aug.
Abstract
Causes for immunosenescence and inflamm-aging have to be established. Efficient function of the immune system requires homeostatic regulation from receptor recognition of antigenic challenge to cell responses and adaptation to its changing environment. It is reasonable to assume that one of the most important molecular causes of immunosenescence is alteration in the regulation of signaling pathways. Indeed, alterations in feed-forward and negative feedback (inhibitory) signaling have been highlighted in all cells involved in the immune response including short-lived (neutrophils) and long-lived (T lymphocytes) cells. These dysregulations tip the balance in favor of altered (less efficient) function of the immune system. In this review, we summarize our knowledge on signal transduction changes in the aging immune system and propose a unifying mechanism as one of the causes of immunosenescence. Modulation of these pathways with aging represents a major challenge to restore the immune response to functional levels.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
- Do membrane rafts contribute to human immunosenescence?
Tomoiu A, Larbi A, Fortin C, Dupuis G, Fulop T Jr. Tomoiu A, et al. Ann N Y Acad Sci. 2007 Apr;1100:98-110. doi: 10.1196/annals.1395.008. Ann N Y Acad Sci. 2007. PMID: 17460168 Review. - NK and NKT cell functions in immunosenescence.
Mocchegiani E, Malavolta M. Mocchegiani E, et al. Aging Cell. 2004 Aug;3(4):177-84. doi: 10.1111/j.1474-9728.2004.00107.x. Aging Cell. 2004. PMID: 15268751 Review. - Immune receptor signaling, aging and autoimmunity.
Larbi A, Fülöp T, Pawelec G. Larbi A, et al. Adv Exp Med Biol. 2008;640:312-24. doi: 10.1007/978-0-387-09789-3_21. Adv Exp Med Biol. 2008. PMID: 19065799 Review. - The role of immunity in elderly cancer.
Malaguarnera L, Cristaldi E, Malaguarnera M. Malaguarnera L, et al. Crit Rev Oncol Hematol. 2010 Apr;74(1):40-60. doi: 10.1016/j.critrevonc.2009.06.002. Epub 2009 Jul 4. Crit Rev Oncol Hematol. 2010. PMID: 19577481 Review. - Immune receptor signaling, aging, and autoimmunity.
Hasler P, Zouali M. Hasler P, et al. Cell Immunol. 2005 Feb;233(2):102-8. doi: 10.1016/j.cellimm.2005.04.012. Cell Immunol. 2005. PMID: 15936745 Review.
Cited by
- Emerging ST121/agr4 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with strong adhesin and cytolytic activities: trigger for MRSA pneumonia and fatal aspiration pneumonia in an influenza-infected elderly.
Wan TW, Tomita Y, Saita N, Konno K, Iwao Y, Hung WC, Teng LJ, Yamamoto T. Wan TW, et al. New Microbes New Infect. 2016 May 26;13:17-21. doi: 10.1016/j.nmni.2016.05.011. eCollection 2016 Sep. New Microbes New Infect. 2016. PMID: 27358743 Free PMC article. - Inflammatory Endotypes and Microbial Associations in Chronic Rhinosinusitis.
Hoggard M, Waldvogel-Thurlow S, Zoing M, Chang K, Radcliff FJ, Wagner Mackenzie B, Biswas K, Douglas RG, Taylor MW. Hoggard M, et al. Front Immunol. 2018 Sep 19;9:2065. doi: 10.3389/fimmu.2018.02065. eCollection 2018. Front Immunol. 2018. PMID: 30283438 Free PMC article. - Zinc deficiency enhanced inflammatory response by increasing immune cell activation and inducing IL6 promoter demethylation.
Wong CP, Rinaldi NA, Ho E. Wong CP, et al. Mol Nutr Food Res. 2015 May;59(5):991-9. doi: 10.1002/mnfr.201400761. Epub 2015 Mar 17. Mol Nutr Food Res. 2015. PMID: 25656040 Free PMC article. - Immune Checkpoints Inhibitors and Chemotherapy as First-Line Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase III Clinical Trials.
Chen HL, Chan VW, Tu YK, Chan EO, Chang HM, Juan YS, Teoh JY, Lee HY. Chen HL, et al. Cancers (Basel). 2021 Mar 23;13(6):1484. doi: 10.3390/cancers13061484. Cancers (Basel). 2021. PMID: 33807108 Free PMC article. - Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potential.
Baldini C, Champiat S, Vuagnat P, Massard C. Baldini C, et al. Onco Targets Ther. 2019 Apr 3;12:2505-2512. doi: 10.2147/OTT.S141040. eCollection 2019. Onco Targets Ther. 2019. PMID: 31040693 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical